Legend

Session Format

In Person

Livestreamed

On Demand

All times listed are Pacific Standard Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.

Type here to filter the list

Sunday, Nov 12th
7:30 AM – 8:30 AM PT
12S101: ACR Guidelines: Interstitial Lung Disease (ILD)
Location: Ballroom 20D
Moderator: Marcy Bolster, MD – Massachusetts General Hospital
Moderator: Michael D. George, MD, MSc – University of Pennsylvania
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Sunday, Nov 12th
7:30 AM – 7:45 AM PT
Developing the Systemic Autoimmune Rheumatic Disease-ILD Guidelines
Location: Ballroom 20D
Speaker: Elana J. Bernstein, MD, MSc – Columbia University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
7:45 AM – 8:00 AM PT
Presentation of the Systemic Autoimmune Rheumatic Disease-Interstitial Lung Disease Screening, Monitoring, and Treatment Guidelines
Location: Ballroom 20D
Speaker: Sindhu Johnson, MD, PhD – University of Toronto
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
8:00 AM – 8:15 AM PT
Using the Systemic Autoimmune Rheumatic Disease-ILD Guidelines
Location: Ballroom 20D
Speaker: Dinesh Khanna, MD, MSc – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
8:15 AM – 8:30 AM PT
Q&A
Location: Ballroom 20D
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 10:00 AM PT
12S112: Meet the Panel: Case-based ILD
Location: Ballroom 20D
Moderator: DeAnna Baker Frost, MD, PhD – Medical University of South Carolina
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Sunday, Nov 12th
9:00 AM – 9:45 AM PT
Meet the Panel: Case-Based Interstitial Lung Disease
Location: Ballroom 20D
Panelist: Christopher Denton, MD, PhD – University College London, UK
Panelist: Oliver Distler, MD – Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Panelist: Elizabeth R. Volkmann, MD, MS – University of California, Los Angeles
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:45 AM – 10:00 AM PT
Q&A
Location: Ballroom 20D
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
(0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research
Location: Poster Hall
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0609: Mortality After Autologous Hematopoietic Stem Cell Transplant for Autoimmune Disease: Do Scleroderma Patients Fare Worse?
Location: Poster Hall
Abstract Poster Presenter: Marie Hudson, MD, MPH – McGill University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0610: Nailfold Capillaroscopy for Prediction of Novel Severe Organ Involvement in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0611: Demographics and Clinical Features Associated with Small Bowel Hypomotility in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Jenice Cheah, MD – UCLA
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0612: COVID Vaccinations and Infections Among Individuals with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study
Location: Poster Hall
Abstract Poster Presenter: Jessica Gordon, MD, MSc – Hospital for Special Surgery
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0613: Quantification of Skin Hardness of Patients with Systemic Sclerosis Using SOFTGRAM
Location: Poster Hall
Abstract Poster Presenter: Hiraku Kokubu, MD (he/him/his) – Shiga University of Medical Science, Graduate School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0614: Self-Reported Sexual Dysfunction and Perceptions of Rheumatologist Engagement on This Issue in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Liza Morales, BA (she/her/hers) – Hospital for Special Surgery
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0615: Prevalence of Barrett’s Esophagus in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: FNU Rida Ul Jannat, MD – West Virginia University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0616: Does Systemic Sclerosis Affect the Interpretation of Mammograms? A Retrospective Cohort Study
Location: Poster Hall
Abstract Poster Presenter: Tegveer Sandhu, MBBS – Markham Rheumatology Hub
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0617: Pulmonary Rehabilitation in Connective Tissue Disease-Related Interstitial Lung Diseases
Location: Poster Hall
Abstract Poster Presenter: Rosemary Gedert, MS – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0618: Incident versus Prevalent Interstitial Lung Disease in Systemic Sclerosis in the EUSTAR Database: Different Disease Phenotypes and Prognosis
Location: Poster Hall
Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich & University of Florence
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0619: Different Definitions of Disease Severity, Progression and Outcomes in Systemic Sclerosis Associated Interstitial Lung Disease: A Systematic Literature Review
Location: Poster Hall
Abstract Poster Presenter: Liubov Petelytska, MD, PhD – Bogomolets National Medical University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0620: Physical and Mental Health in Early Systemic Sclerosis: Baseline Results for Patient-Reported Outcomes Measurement Information System-29 from the Collaborative National Quality and Efficacy Registry
Location: Poster Hall
Abstract Poster Presenter: Isha Lamba, MD (she/her/hers) – New York Presbyterian Hospital/Weill Cornell Medical Centre
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0621: Scleroderma Renal Crisis: A Large Single-center Experience
Location: Poster Hall
Abstract Poster Presenter: Rushab Shah, MD (he/him/his) – Alfred Hospital, Melbourne, Australia
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0622: The Effectiveness of Breath-holding Test to Predict Pulmonary Function in Systemic Sclerosis Patients Using Machine Learning Model
Location: Poster Hall
Abstract Poster Presenter: Jina Yeo, MD (she/her/hers) – Gachon University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0623: Nailfold Capillaroscopy in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib
Location: Poster Hall
Abstract Poster Presenter: Vanessa Smith, MD, PhD, -None- – Ghent University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0624: Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Based on Serological Profiles: Focus on Anti-Centromere Antibody (ACA) and Anti-RNA Polymerase III (ARA) Antibodies
Location: Poster Hall
Abstract Poster Presenter: Elizabeth R. Volkmann, MD, MS – University of California, Los Angeles
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0625: Use of Heated Gloves for Raynaud’s Phenomenon in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Kimti Kumar, MBBS, BSc, FRACP – University of Adelaide
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0626: Clinical Features of Anti-hUBF Antibodies-positive Patients: A Single-center Retrospective Study
Location: Poster Hall
Abstract Poster Presenter: Natsumi Fushida, MD – Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0627: Clinical Significance of Anti-Ro/SSA Antibodies in Patients with Systemic Sclerosis: A Study from the EUSTAR Database
Location: Poster Hall
Abstract Poster Presenter: Blaz Burja, MD – Zurich, Switzerland
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0628: Interstitial Lung Disease in Very Early Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich & University of Florence
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0629: Negative Affect, Anxiety and Fatigue Moderate the Association Between Pain Intensity and Physical Function in People with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Daniel Whibley, PhD – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0630: Prevalence and Risk Factors for Systemic Sclerosis Digital Ischemic Complications in the Collaborative National Quality and Efficacy Registry
Location: Poster Hall
Abstract Poster Presenter: Marissa Savoie, MD – Massachusetts General Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0631: Safety of Radiotherapy for Malignancy in Systemic Sclerosis. a Systematic Review
Location: Poster Hall
Abstract Poster Presenter: Aos Aboabat, MBBS, FRCPC – University of Toronto
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0632: A Longitudinal Analysis of Mouth Opening in 1101 Systemic Sclerosis Patients from the French National Cohort Study
Location: Poster Hall
Abstract Poster Presenter: Benjamin Chaigne, MD, PhD – Paris Cité University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0633: Prediction of Progressive Fibrosing Interstitial Lung Disease in Systemic Sclerosis Patients: Insight from the CRDC Cohort Study
Location: Poster Hall
Abstract Poster Presenter: Min Hui, MD – Department of Rheumatology, Peking Union Medical College Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0634: Prevalence and Associations of Anaemia in Systemic Sclerosis Patients in a National Observational Cohort; Results from the Australian Scleroderma Cohort Study
Location: Poster Hall
Abstract Poster Presenter: Raychel Barallon, MD – Monash Health
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0635: Clinical Characteristics and Longitudinal Outcomes of Patients with Childhood-Onset Systemic Sclerosis at a Tertiary Center
Location: Poster Hall
Abstract Poster Presenter: Jessica Nguyen, MD – Baylor College of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0636: Chasing Pain: Investigating Somatosensory Profiles in Patients with Rheumatological Diseases Using Quantitative Sensory Testing
Location: Poster Hall
Abstract Poster Presenter: Claus Juergen Bauer, MD – Clinic of Internal Medicine III, Department of Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0637: Comparison of Four Risk Stratification Models for Prediction of Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in the EUSTAR Cohort
Location: Poster Hall
Abstract Poster Presenter: Hilde Jenssen Bjørkekjær, MD (she/her/hers) – Department of Rheumatology, Hospital of Southern Norway, Kristiansand
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0638: Application of the 2022 European Society of Cardiology (ESC) Risk Assessment Model in Australian and Singaporean Systemic Sclerosis Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH)
Location: Poster Hall
Abstract Poster Presenter: Mandana Nikpour, PhD, MBBS – The University of Sydney
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0639: Evaluating Esophageal Dysmotility by Scintigraphy in Systemic Sclerosis: Subsets and Phenotypes
Location: Poster Hall
Abstract Poster Presenter: Antonio Salas, MD – Johns Hopkins University School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0640: Multidisciplinary and Multiparametric Evaluation of Sarcopenia in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Marta Mosca, MD, PhD – University of Pisa
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0641: The Evaluation of Lower Extremities Arterial Disease in Systemic Sclerosis Patients Through Rheumatologist-Vascular Surgeon Multidisciplinary Management: Preliminary Data from an Italian Single Center Study
Location: Poster Hall
Abstract Poster Presenter: Maria Grazia Lazzaroni, MD, PhD (she/her/hers) – ASST Spedali Civili di Brescia
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0642: Clinical Characteristics of Systemic Sclerosis, Systemic Sclerosis Overlap Syndromes and Systemic Sclerosis-mixed Connective Tissue Disease in an Asia-Pacific Cohort- an APLAR Scleroderma Special Interest Group Study
Location: Poster Hall
Abstract Poster Presenter: Andrea Low, MBBS, BSc, MRCP – Singapore General Hospital, SingHealth; Duke-NUS
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0643: Progression of Interstitial Lung Disease in Systemic Sclerosis Does Not Predict Further Progression
Location: Poster Hall
Abstract Poster Presenter: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0644: Prediction of Stable SSc-ILD Depends on Definition of ILD Progression
Location: Poster Hall
Abstract Poster Presenter: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0645: Continuous Progressive ILD in Systemic Sclerosis Is Associated with Mortality
Location: Poster Hall
Abstract Poster Presenter: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0646: Racial Variability in Immune Responses Only Partially Explains Differential Systemic Sclerosis Disease Severity
Location: Poster Hall
Abstract Poster Presenter: Kamini Kuchinad, MD, MPH – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0647: Prevalence and Risk Factors of Left Ventricular Diastolic Dysfunction in Systemic Sclerosis: Insights from New Echocardiographic Parameters
Location: Poster Hall
Abstract Poster Presenter: Irene Carrión-Barberà, MD – Hospital del Mar
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0648: Incidence and Prevalence of Malnutrition and Its Impact on Mortality in the Multicentre Singapore Systemic Sclerosis Cohort
Location: Poster Hall
Abstract Poster Presenter: Andrea Low, MBBS, BSc, MRCP – Singapore General Hospital, SingHealth; Duke-NUS
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0649: Early Systemic Sclerosis Definitions: Time to Rethink ‘Early’ in SSc Disease?
Location: Poster Hall
Abstract Poster Presenter: Francesco Del Galdo, MD, PhD (he/him/his) – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0650: Understanding the Employment Landscape in People with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Hila Jazayeri, MD, MSc (she/her/hers) – University of Toronto
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0651: Abnormal Nailfold Video-capillaroscopy Is Independently Associated with non-UIP Radiographic Patterns in Autoimmune ILD: A Multicenter Study from the NEREA Registry
Location: Poster Hall
Abstract Poster Presenter: Jesús Loarce, Sr, MD – Ramón y Cajal University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0652: Ethnic Variations in Systemic Sclerosis Associated Interstitial Lung Disease
Location: Poster Hall
Abstract Poster Presenter: Patrick Donio, MD – Queen's University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0653: Association Between Systemic Sclerosis and Increased Risk of Ischemic Stroke: A Meta-Analysis
Location: Poster Hall
Abstract Poster Presenter: Konstantinos Parperis, MD, FACP, FACR – University of Cyprus Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0654: Comparison of Cardiovascular Risk in Patients with Systemic Sclerosis and the General Population
Location: Poster Hall
Abstract Poster Presenter: Michal Tomcik, MD, PhD – Institute of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0655: A Novel Association Between Lipodermatosclerosis and Key Vascular Outcomes in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Srijana Davuluri, MD, MS – Stanford School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0656: Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression
Location: Poster Hall
Abstract Poster Presenter: Enrico De Lorenzis, MD – Catholic University of the Sacred Heart
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0657: The Value of the Six-Minute Walk Test in Detecting Cardiopulmonary Involvement in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Jeska de Vries-Bouwstra, MD, PhD – Leiden University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0658: Evaluating the Associations Between Autonomic Dysfunction, Clinical Phenotype and Gastrointestinal Transit in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Maria Paula Alvarez, MD (she/her/hers) – Hospital Universitario de La Princesa
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0659: Cigarette Exposure in Systemic Sclerosis: Impact on Autoantibody Expression and Disease Manifestations: Analysis of the EUSTAR Cohort
Location: Poster Hall
Abstract Poster Presenter: Jeska de Vries-Bouwstra, MD, PhD – Leiden University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0660: Cigarette Smoking Increases the Risk of All-Cause Mortality in Male Patients with Systemic Sclerosis: An Analysis of the EUSTAR Cohort
Location: Poster Hall
Abstract Poster Presenter: Jeska de Vries-Bouwstra, MD, PhD – Leiden University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0661: Assessment of Systemic Sclerosis-Associated Myocarditis: A Single Center Case Series Study
Location: Poster Hall
Abstract Poster Presenter: Nafsika Gerolymatou, MD – Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0662: Changes in Treatment Patterns and Their Influence on the Outcome of Systemic Sclerosis-interstitial Lung Disease (SSc-ILD) Patients: An EUSTAR Analysis
Location: Poster Hall
Abstract Poster Presenter: Corrado Campochiaro, MD – IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0663: Vaccine-Preventable Diseases in Hospitalized Patients with Systemic Sclerosis: A Nationwide Cohort Analysis
Location: Poster Hall
Abstract Poster Presenter: Saman Tanveer, MD, MBBS (she/her/hers) – John H. Stroger Jr. Hospital of Cook County
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0664: Quantitative Hand Held Dynamometry to Assess Muscle Strength in Scleroderma Associated Myopathy
Location: Poster Hall
Abstract Poster Presenter: Anshula Nallapati, BS – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0665: A Descriptive Study of Disease Characterisics of SSc Patients with the U2RNP Autoantibody
Location: Poster Hall
Abstract Poster Presenter: Mridula Dilip, MD – University of Pittsburgh School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0666: Troponin I Levels in Systemic Sclerosis Patients with Myocardial Involvement
Location: Poster Hall
Abstract Poster Presenter: Eva Hoekstra, MD, MSc – Leiden University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0667: The Risk of Stroke and Myocardial Infarction in Systemic Sclerosis: A Population-based Study
Location: Poster Hall
Abstract Poster Presenter: Jiwon Hwang, MD, PhD – Samsung Changwon Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0668: Increased Risk of Cancer in Patients with Systemic Sclerosis: A Population-based Study
Location: Poster Hall
Abstract Poster Presenter: Jiwon Hwang, MD, PhD – Samsung Changwon Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0669: Optical Coherence Tomography Angiography in Systemic Sclerosis: Correlations with Morphological and Functional Peripheral Microvascular Status
Location: Poster Hall
Abstract Poster Presenter: Maurizio Cutolo, MD – University of Genova
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0670: Title: Patient Characteristics and Outcomes of Scleroderma Renal Crisis versus Hypertensive Emergencies: A Nationwide Comparative Study
Location: Poster Hall
Abstract Poster Presenter: Husam El Sharu, MD – East Carolina University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0671: Decreased Odds of Malignancy with Mycophenolate Use in a Single-Center Scleroderma Cohort
Location: Poster Hall
Abstract Poster Presenter: Jin Feng, MD, MPH (she/her/hers) – Icahn School of Medicine at Mount Sinai Morningside and West
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
9:00 AM – 11:00 AM PT
0672: Risk of New-onset Depression in Patients with Systemic Sclerosis : A Nationwide Population-based Study
Location: Poster Hall
Abstract Poster Presenter: Hahee Son, MD (she/her/hers) – Yeouido St. Mary's Hospital, Catholic University of Korea
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
2:00 PM – 3:30 PM PT
12S150: Abstracts: Systemic Sclerosis & Related Disorders I: Translational (0787–0792)
Location: Room 6F/6C
Abstract Moderator: Andreea Bujor, MD, PhD – Boston University
Abstract Moderator: Masataka Kuwana, MD, PhD – Nippon Medical School Graduate School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
2:00 PM – 2:10 PM PT
0787: Understanding Distinct Resident and Migratory Fibroblast Populations in Systemic Sclerosis Skin Through Single-cell RNAseq and Immunohistochemistry
Location: Room 6F/6C
Presenting Author: Kristina Clark, MD, PhD, MRCP – University College London
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
2:15 PM – 2:25 PM PT
0788: Whole Exome Sequencing and Evolutionary Action Missense Mutation Analysis Identifies MICB as a New SSc Susceptibility Locus and the Interferon Pathway as Contributors to SSc Pathogenesis
Location: Room 6F/6C
Presenting Author: Shamika Ketkar, PhD (she/her/hers) – Baylor College of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
2:30 PM – 2:40 PM PT
0789: Telomere Length of Peripheral Blood Cells Predicts More Severe Pulmonary Disease and Worse Survival in Systemic Sclerosis
Location: Room 6F/6C
Presenting Author: Monica Yang, MD – UCSF
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
2:45 PM – 2:55 PM PT
0790: Transcriptomic Analyses of Lung Tissues Reveals Potential Key Genes Associated with Progression of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD)
Location: Room 6F/6C
Presenting Author: Yehya Al-Adwi, BSc, MSc (he/him/his) – UMCG
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
3:00 PM – 3:10 PM PT
0791: Expression of TL1A, Inflammatory, and Fibrotic Pathways in Patients with Diffuse Systemic Sclerosis
Location: Room 6F/6C
Presenting Author: Heather Llewellyn – Merck Inc
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Sunday, Nov 12th
3:15 PM – 3:25 PM PT
0792: Single Cell RNA-seq of Myeloid Cells from Systemic Sclerosis Patients Identifies Circulating Monocyte Population with Interferon Signature Associated with Interstitial Lung Disease
Location: Room 6F/6C
Presenting Author: Richard Ainsworth, PhD – Cedars-Sinai
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
8:00 AM – 9:00 AM PT
13M109: Developing Thick Skin in the Lab: Preclinical Models to Enable Personalized Medicine in Scleroderma
Location: Room 32A-B
Moderator: Eliza Pei-Suen Tsou, PhD – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Monday, Nov 13th
8:00 AM – 8:15 AM PT
Lessons Learned from Pre-Clinical Models of Scleroderma
Location: Room 32A-B
Speaker: Carol Feghali-Bostwick, PhD – Medical University of South Carolina
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
8:15 AM – 8:30 AM PT
Organoid Approaches to Studying Scleroderma Skin and Lung
Location: Room 32A-B
Speaker: Jörg Distler, MD – University Hospital Duesseldorf and HHU
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
8:30 AM – 8:45 AM PT
Self-Assembled Skin Equivalents and Other Advanced Systems to Study Skin Fibrosis
Location: Room 32A-B
Speaker: Michael Whitfield, PhD – Geisel School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
8:45 AM – 9:00 AM PT
Q&A
Location: Room 32A-B
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
(0934–0964) Systemic Sclerosis & Related Disorders – Basic Science Poster
Location: Poster Hall
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
(1513–1533) Systemic Sclerosis & Related Disorders – Clinical Poster II: Clinical Trial, Treatment & Intervention
Location: Poster Hall
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0934: Anti-fibrotic Effects of MT-5562, a Novel Potent Selective Autotaxin Inhibitor, in Preclinical Studies: Roles of Lysophosphatidic Acid in Autoimmune Diseases and Clues to Treat Skin and Lung Fibrosis in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Hiroshi Matsuura, PhD (he/him/his) – Mitsubishi Tanabe Pharma Corporation
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0935: Sodium Pyruvate Improves Mitochondrial Fitness in SSc Fibroblasts to Prevent Fibroblast-to-myofibroblast Transition and Fibrotic Remodeling
Location: Poster Hall
Abstract Poster Presenter: Xiang Zhou, MSc – Heinrich Heine University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0936: Impaired DNA Repair Responses Activate a Novel FOXO1-dependent Metabolic Remodelling in Patients with Progressive Systemic Sclerosis to Promote Fibrosis
Location: Poster Hall
Abstract Poster Presenter: Lamia Khan, MSc – University of Alberta
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0937: IL-4+ and IFN-α+ Profibrotic T Cells Aggravate Systemic Sclerosis via STIM1/STING Signaling in SKG Mice
Location: Poster Hall
Abstract Poster Presenter: Jiwon Yang, MD – The Catholic University of Korea
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0938: Deconvolution of the Molecular Signature of Very Early Diagnosis of Systemic Sclerosis (VEDOSS) and Established Disease: A Biomarker Blueprint of Scleroderma Disease Continuum
Location: Poster Hall
Abstract Poster Presenter: Sunhwa Kim, PhD – AbbVie
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0939: HRCT-derived Delta Radiomic Features Classify Response to Anti-Fibrotic Treatment in Experimental and Human Fibrosing Interstitial Lung Disease
Location: Poster Hall
Abstract Poster Presenter: David Lauer, BSc, MSc – University Hospital Bern
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0940: A Novel Therapeutic Opportunity in Systemic Sclerosis: The Fibrolytic Activities of a Specialized Macrophage Secretome
Location: Poster Hall
Abstract Poster Presenter: Sylvain Perruche, PhD – Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Institute/MedINNPharma
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0941: RUNX1 Expression and Binding Site Accessibility Is Associated with Increased Disease Severity in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Rezvan Parvizi, PharmD, MSc – Dartmouth
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0942: WITHDRAWN
Location: Poster Hall
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0943: Attenuation of Fibroblast Activation and Fibrosis by Adropin in a Hedgehog-Dependent Manner
Location: Poster Hall
Abstract Poster Presenter: Minrui Liang (she/her/hers) – Universitätsklinikum Düsseldorf Heinrich-Heine-Universität Düsseldorf
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0944: Macrophages Regulate Adipocyte Differentiation and Proliferation in Skin Fibrosis
Location: Poster Hall
Abstract Poster Presenter: Chanhyuk Park, BA – Geisel School of Medicine at Dartmouth
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0945: The Nuclear Receptor TR4 Orchestrates Cytoskeletal Organization in a Gα12/ROCK-dependent Manner to Promote Myofibroblast Differentiation and Tissue Fibrosis in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Jörg Distler, MD – University Hospital Duesseldorf and HHU
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0946: Immunoglobulins G Purified from Systemic Sclerosis Patients Influence Cytoplasmic and Nuclear Proteins Profile in Dermal Fibroblasts
Location: Poster Hall
Abstract Poster Presenter: Aurélien Chepy, MD (he/him/his) – INFINTE U186 inserm, univeristy of Lille
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0947: Fcγ Receptors Define Pro-Phagocytic Macrophages and Trigger Pro-Inflammatory Responses in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Amela Hukara, MSc – University Hospital Zurich, University of Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0948: Nintedanib Alters Fibroblast and Macrophage Diversity in a 3D Skin Model of Systemic Sclerosis (SSc)
Location: Poster Hall
Abstract Poster Presenter: Michael Whitfield, PhD – Geisel School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0949: Development of Interstitial Pneumonia with Autoimmune Features in Conditional Tgfb3 Deletion
Location: Poster Hall
Abstract Poster Presenter: Toshihiko Komai, MD, PhD – The University of Tokyo
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0950: KL-6 and IL-18 Levels Are Negatively Correlated with Respiratory Function Tests and ILD Extent Assessed on HRCT in Patients with Systemic Sclerosis-related Interstitial Lung Disease (SSc-ILD)
Location: Poster Hall
Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0951: Single Cell Analysis of Transitional B Cells in Systemic Sclerosis Highlights Defective Peripheral Tolerance
Location: Poster Hall
Abstract Poster Presenter: Claire Beesley, BSc (she/her/hers) – University College London
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0952: Unraveling the Role of MiR-181 in Skin Fibrosis Pathogenesis by Targeting NUDT21
Location: Poster Hall
Abstract Poster Presenter: Tingting Mills, PhD – UThealth-Houston
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0953: Flavin-containing Monooxygenase (FMO3) Links the Gut and Fibrosis in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Priyanka Verma, PhD (she/her/hers) – Department of Internal Medicine, Michigan Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0956: Effects of B Cell Depletion by CD19-targeted CAR-T Cells in a Murine Model of Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Jérôme Avouac, MD, PhD – Université de Paris Cité
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0957: Rationale for Targeting Insulin-like Growth Factor Signalling in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Voon Ong, PhD, FRCP – UCL Medical School Royal Free Campus
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0958: Shared Genetic Susceptibility Between Systemic Sclerosis and Primary Biliary Cholangitis: Analyses from Genome-Wide Association Studies
Location: Poster Hall
Abstract Poster Presenter: Yiming Luo, MD, MHS – Columbia University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0959: WITHDRAWN
Location: Poster Hall
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0960: MiR-3606-3p Alleviates Skin Fibrosis by Suppressing Fibroblast Inflammation and Migration via Inhibiting GAB1 and ITGAV
Location: Poster Hall
Abstract Poster Presenter: Yahui Chen, PhD – Fudan university
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0961: Transcriptomic Analysis of Scleroderma Monocytes Identifies Distinct Clinically Relevant Clusters and Novel Genes Associated with Disease Complications
Location: Poster Hall
Abstract Poster Presenter: Mehmed Dinc, MD – Boston Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0962: Topological Proteomic Differences in Fibrotic and Unaffected Skin in Scleroderma
Location: Poster Hall
Abstract Poster Presenter: Irene Choi, MS (she/her/hers) – Cedars-Sinai Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0963: Anti-Topoisomerase Antibody in dcSSc: Unravelling Its Intracellular Effects in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Maithri Aspari, MD – Aarhus University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
0964: Systemic Sclerosis (SSc) Dermal Fibroblasts Show Shortened Primary Cilia Due to Aberrant Aurora a Kinase Activation Independently of Transforming Growth Factor β Signalling
Location: Poster Hall
Abstract Poster Presenter: Francesco Del Galdo, MD, PhD (he/him/his) – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1513: Trends in Systemic Sclerosis- related Mortality by Age, Sex and Race in the United States, 1999-2019
Location: Poster Hall
Abstract Poster Presenter: Emily He, MD, MS – Loma Linda University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1514: Phase I Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Interstitial Lung Disease in Patients with Connective Tissue Disorders
Location: Poster Hall
Abstract Poster Presenter: Andy Abril, MD (he/him/his) – Mayo Clinic
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1515: Performance of the Revised CRISS in a Phase 3 Trial of Early Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1516: Systemic Sclerosis Gastrointestinal Tract Vascular Biomarkers of Symptomatic Disease Activity
Location: Poster Hall
Abstract Poster Presenter: Venkateswara Reddy Gogulamudi, PhD (he/him/his) – University of Utah
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1517: Comparing Deep Neural Network to Modified Rodnan Skin Score in a Trial for Belumosudil in Systemic Sclerosis Patients
Location: Poster Hall
Abstract Poster Presenter: Baran Gunes, BA (she/her/hers) – Yale University School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1518: Efficacy and Safety of Prostaglandins Analogues in Systemic Sclerosis-associated Raynaud’s Phenomenon. a Systematic Review and Meta-Analysis
Location: Poster Hall
Abstract Poster Presenter: Hana Salem Alahmari, Dr, MBBS, MSc, MRCP – King Khalid University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1519: Renal Complications Following Autologous Stem Cell Transplantation for Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Malcolm MacKenzie, MD – University of Ottawa
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1520: Identifying Core Domains for Clinical Trials in Systemic Sclerosis-Associated Raynaud’s Phenomenon and Digital Ulcers Using the Delphi Consensus Method
Location: Poster Hall
Abstract Poster Presenter: Susanna Proudman, MBBS – Royal Adelaide Hospital and University of Adelaide
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1521: Microvascular Remodeling After Autologous Stem Cell Transplant for Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Lisa Balistreri, MD (she/her/hers) – Mayo Clinic Florida
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1522: Treatment of Pulmonary Arterial Hypertension in Patients with Connective Tissue Diseases: A Meta-analysis
Location: Poster Hall
Abstract Poster Presenter: Sinem Esatoglu, MD – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1523: The Risk of Scleroderma Renal Crisis from Intraarticular Corticosteroid Injection in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Eyerusalem Akpan, MD (she/her/hers) – University of New Mexico
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1524: The Effectiveness of Nintedanib in Treating Fibrosing Interstitial Lung Disease in Both Scleroderma and Non-scleroderma Patients: A Systematic Review and Meta-analysis
Location: Poster Hall
Abstract Poster Presenter: Yasmin Khader, MD, MPH – University of Toledo
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1525: Chelation Therapy in the Management of Calcinosis Associated with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Alison Fernandes, MD (she/her/hers) – Aurora
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1526: Evusheld Efficacy and Safety in Autoimmune Rheumatic Diseases (AIRD) Treated by B Cell Depeting Therapy or Autologous Stem Cell Transplantation: A Prospective Observational Study
Location: Poster Hall
Abstract Poster Presenter: Lisa Kaly, MD, BAO – BNAI ZION MEDICAL CENTER
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1527: Acute Effects of Intravenous Iloprost on Finger Power Doppler Ultrasound in Scleroderma Patients
Location: Poster Hall
Abstract Poster Presenter: Sofia Testoni, MD – Università degli Studi di Modena e Reggio Emilia
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1528: Intravenous or Subcutaneous Immunoglobulins as Potential Treatment for Gastrointestinal, Cutaneous and Vascular Involvement in Systemic Sclerosis: Data from an Italian Cohort of 65 Patients
Location: Poster Hall
Abstract Poster Presenter: Francesco Bonomi, MD (he/him/his) – Azienda Ospedaliera Universitaria Careggi
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1529: Mycophenolate Mofetil Use in Clinical Practice: Persistence on Therapy and Long-term Adverse Events in a Multicentric Cohort of Scleroderma Patients
Location: Poster Hall
Abstract Poster Presenter: Gerlando Natalello, MD – Division of Rheumatology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1530: Outcomes in Patients with Systemic Sclerosis Following Lung Transplantation: An Italian Multicentre Experience
Location: Poster Hall
Abstract Poster Presenter: Claudia Iannone, MD (she/her/hers) – University of Milan, Gaetano Pini CTO
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1531: A Retrospective Analysis of the Efficacy of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD): A TriNetX Database Study
Location: Poster Hall
Abstract Poster Presenter: Jasmeen Uppal, MD – LSUHSC
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1532: Safety and Microvascular Effects of Long-term Treatment with Aminaphtone in Systemic Sclerosis Patients: A Retrospective Analysis
Location: Poster Hall
Abstract Poster Presenter: Alberto Sulli, MD – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
9:00 AM – 11:00 AM PT
1533: Long-term Use of Rituximab in Systemic Sclerosis: A Real-life Italian Multicentre Study
Location: Poster Hall
Abstract Poster Presenter: Giacomo De Luca, MD – Vita-Salute San Raffaele University & IRCCS San Raffaele Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
12:00 PM – 1:00 PM PT
13M125: Fibroblasts as Iconoclasts: New Functional Roles of Mesenchymal Cells in Health and Disease
Location: Room 25A-C
Moderator: Sandeep Agarwal, MD, PhD – Baylor College of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Monday, Nov 13th
12:00 PM – 12:15 PM PT
Epigenetic and Transcriptional Regulation of Myofibroblasts in Skin and Lung Fibrosis
Location: Room 25A-C
Speaker: Robert Lafyatis, MD – University of Pittsburgh
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
12:15 PM – 12:30 PM PT
Characterization of Novel Fibroblast Functions in Rheumatoid Arthritis (RA)
Location: Room 25A-C
Speaker: Michael Brenner, MD – Brigham and Women's Hospital, Harvard Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
12:30 PM – 12:45 PM PT
How Fibroblasts Can Participate in Scarless Regeneration
Location: Room 25A-C
Speaker: Michael Longaker, MD, MBA – Stanford
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
12:45 PM – 1:00 PM PT
Q&A
Location: Room 25A-C
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
2:00 PM – 3:00 PM PT
13M136: Antisynthetase Syndrome: A Distinct Entity
Location: Room 11A-B
Moderator: Sara Faghihi Kashani, MD, MPH – Stanford
Moderator: Christopher Mecoli, MD – Johns Hopkins University School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Monday, Nov 13th
2:00 PM – 2:15 PM PT
The Evolution of Anti-Synthetase Syndrome
Location: Room 11A-B
Speaker: Lorenzo Cavagna, MD – University of Pavia and Fondazione IRCCS Policlinico San Matteo Hospital of Pavia
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
2:15 PM – 2:30 PM PT
The Spectrum of ILD in Anti-Synthetase Syndrome
Location: Room 11A-B
Speaker: Erin Wilfong, MD, PhD (she/her/hers) – Vanderbilt University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
2:30 PM – 2:45 PM PT
The Classification Criteria of Anti-Synthetase Syndrome
Location: Room 11A-B
Speaker: Rohit Aggarwal, MD, MS – University of Pittsburgh
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
2:45 PM – 3:00 PM PT
Q&A
Location: Room 11A-B
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:00 PM – 5:30 PM PT
13M168: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science (1663–1668)
Location: Room 11A-B
Abstract Moderator: Carol Feghali-Bostwick, PhD – Medical University of South Carolina
Abstract Moderator: Zsuzsanna McMahan, MD, MHS – UT Health Houston
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:00 PM – 5:30 PM PT
13M169: Abstracts: Systemic Sclerosis & Related Disorders II: Clinical Research (1699–1704)
Location: Room 29A-D
Abstract Moderator: Lorinda Chung, MD, MS (she/her/hers) – Stanford University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:00 PM – 4:10 PM PT
1663: Clinically Severe Systemic Sclerosis Skin Harbors Inflammatory Fibroblasts Associated with Lymphocytes and Plasmacytoid Dendritic Cells
Location: Room 11A-B
Presenting Author: Dana Orange, MD – The Rockefeller University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:00 PM – 4:10 PM PT
1699: Immunosuppression with Targeted Therapies Reduces Morbidity and Mortality in Pre-Capillary Pulmonary Hypertension Associated with Systemic Sclerosis: A EUSTAR Analysis
Location: Room 29A-D
Presenting Author: Cosimo Bruni, MD, PhD – University of Zurich & University of Florence
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:15 PM – 4:25 PM PT
1664: Fibroblast Specific Interferon Regulatory Factor 7 (IRF7) Expression Is a Key Link Between Type I Interferon Activation and the Exaggerated Dermal and Pulmonary Fibrosis in Systemic Sclerosis
Location: Room 11A-B
Presenting Author: Minghua Wu, MD, PhD – University of Texas Health Science Center at Houston, McGovern Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:15 PM – 4:25 PM PT
1700: Incidence and Risk Factors for New Onset of Interstitial Lung Disease in Systemic Sclerosis: A EUSTAR Analysis
Location: Room 29A-D
Presenting Author: Liubov Petelytska, MD, PhD – Bogomolets National Medical University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:30 PM – 4:40 PM PT
1665: Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis
Location: Room 11A-B
Presenting Author: Hanlin Yin, MD – Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:30 PM – 4:40 PM PT
1701: Treatment Regimens and Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in Light of the 2022 ESC/ERS Guidelines
Location: Room 29A-D
Presenting Author: Hilde Jenssen Bjørkekjær, MD (she/her/hers) – Department of Rheumatology, Hospital of Southern Norway, Kristiansand
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:45 PM – 4:55 PM PT
1666: TNF-mediated Pulmonary Hypertension Is Marked by Aberrant Bone Morphogenic Protein (BMP) and Integrin/Basement Membrane Ligand-Receptor Signaling
Location: Room 11A-B
Presenting Author: Benjamin Korman, MD – University of Rochester
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
4:45 PM – 4:55 PM PT
1702: Outcomes in Systemic Sclerosis Patients Treated with Rituximab and Mycophenolate Mofetil Combination Therapy Compared to Autologous Hematological Stem Cell Transplantation
Location: Room 29A-D
Presenting Author: Doron Rimar, MD (he/him/his) – Bnai Zion medical center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
5:00 PM – 5:10 PM PT
1667: Characterization of the Vascular Niches in Systemic Sclerosis (SSc) as a Prototypical Immune-mediated Fibrotic Disease with Prominent Vasculopathy Using Imaging Mass Cytometry
Location: Room 11A-B
Presenting Author: Minrui Liang (she/her/hers) – Universitätsklinikum Düsseldorf Heinrich-Heine-Universität Düsseldorf
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
5:00 PM – 5:10 PM PT
1703: Increased Mortality and Cardiovascular Events in Male Patients with Systemic Sclerosis: Left Ventricular Global Longitudinal Strain as Possible Screening Tool
Location: Room 29A-D
Presenting Author: Jeska de Vries-Bouwstra, MD, PhD – Leiden University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
5:15 PM – 5:25 PM PT
1668: Cell Specific Molecular Profiling of Scleroderma Associated Interstitial Lung Disease Subtypes
Location: Room 11A-B
Presenting Author: Monica Yang, MD – UCSF
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Monday, Nov 13th
5:15 PM – 5:25 PM PT
1704: Esophageal Mucosal Erosions Can Predict the Deterioration of Lung Function over a Four-year Follow-up Period and Long-term Mortality in Patients with Interstitial Lung Disease Associated with Scleroderma
Location: Room 29A-D
Presenting Author: Enrico De Lorenzis, MD – Catholic University of the Sacred Heart
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 10:00 AM PT
14T116: Iatrogenic Rheumatology: What Rheumatologists Need to Know About Drug-induced Manifestations of Rheumatic Diseases
Location: Room 33A-C
Moderator: David Liew, MBBS, FRACP – Austin Health
Moderator: Namrata Singh, MD, MSc – University of Washington
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Tuesday, Nov 14th
9:00 AM – 9:15 AM PT
Drug-Induced Arthralgia/Arthritis and Drug-Induced Myalgia/Myositis
Location: Room 33A-C
Speaker: Pankti Reid, MD, MPH – University of Chicago Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:15 AM – 9:30 AM PT
Drug-Induced Lupus
Location: Room 33A-C
Speaker: Cecilia Chung, MD, MPH – University of Miami
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:30 AM – 9:45 AM PT
Drug-Induced Vasculitis
Location: Room 33A-C
Speaker: Kevin Byram, MD – Vanderbilt University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:45 AM – 10:00 AM PT
Q&A
Location: Room 33A-C
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
(2352–2369) Systemic Sclerosis & Related Disorders – Clinical Poster III: Translational Science
Location: Poster Hall
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2352: High Serum C-X-C Motif Chemokine Ligand 10 (CXCL10) Potentially Predicts New Onset of Systemic Sclerosis-Interstitial Lung Disease
Location: Poster Hall
Abstract Poster Presenter: Yehya Al-Adwi, BSc, MSc (he/him/his) – UMCG
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2353: Role of Insulin-like Growth Factor Binding Protein-7 (IGFBP7) in Pulmonary Hypertension Pathogenesis and as a Biomarker Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Location: Poster Hall
Abstract Poster Presenter: Ye Jin Jeong, PhD (she/her/hers) – University of Rochester
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2354: Is Midkine a Novel Biomarker for Acro-osteolysis in Systemic Sclerosis?
Location: Poster Hall
Abstract Poster Presenter: Ganiat Adeogun, MBBS (she/her/hers) – Vanderbilt University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2355: Proteome-based Stratification of Therapeutic Target Population for MT-6194 in Systemic Sclerosis with Pulmonary Arterial Hypertension
Location: Poster Hall
Abstract Poster Presenter: Yuuichi Ono, MS (he/him/his) – Mitsubishi Tanabe Pharma Corporation
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2356: A Macrophage-Specific Mechanism for Mycophenolate Mofetil in the Treatment of Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Emily Morris, PhD (they/them/theirs) – Dartmouth College
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2357: The Involvement of CCR3-CCL24 Axis in Endothelial to Mesenchymal Transition Process and Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
Location: Poster Hall
Abstract Poster Presenter: Ilan Vaknin, PhD, MBA – Chemomab ltd
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2358: Neutrophil Extracellular Traps Induce Endothelial-to-Mesenchymal Transition and Associate with Vascular Complications in Scleroderma
Location: Poster Hall
Abstract Poster Presenter: Ramadan Ali, PhD – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2359: Reversal of the Activation State of Pro-fibrotic CD206 Positive Macrophages by Therapeutic Peptide AUR300 in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Richard Stratton, MD, PhD, FRCP, MA – UCL
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2360: Systemic Sclerosis Macrophages Stimulate Calcinosis in Adipose Derived Mesenchymal Stem Cells via the Activin a Pathway
Location: Poster Hall
Abstract Poster Presenter: Richard Stratton, MD, PhD, FRCP, MA – UCL
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2361: Optimal Combination of Circulating Biomarkers for Predicting the Progression of Interstitial Lung Disease in Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Keina Yomono, MD – Nippon medical school university
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2362: Identification of Protein Biomarkers Associated with the Severity and Risk of Progression of Interstitial Lung Disease in VEDOSS and Established Systemic Sclerosis Patients
Location: Poster Hall
Abstract Poster Presenter: Francesco Del Galdo, MD, PhD (he/him/his) – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2363: Increase in Macrophage Infiltration in Scleroderma Esophageal Mucosa Is Associated with Motility and Mucosal Complications
Location: Poster Hall
Abstract Poster Presenter: Tai-Ju Lee, MD (he/him/his) – National Taiwan University Hospital Hsinchu Branch
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2364: Circulating CTHRC1 Levels Are Associated with Disease Severity and Predict Survival in Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Monica Yang, MD – UCSF
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2365: Decoding the Peripheral Immune Landscape of Systemic Sclerosis to Investigate Disease Stages and Interstitial Lung Disease Progression
Location: Poster Hall
Abstract Poster Presenter: Vasuki Ranjani Chellamuthu, PhD – SingHealth/Translational Immunology Institute
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2366: Spatial Frequency Domain Imaging as a Novel Method to Quantify Longitudinal Skin Changes in Scleroderma
Location: Poster Hall
Abstract Poster Presenter: Hung Vo, MD – Boston Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2367: Characterization of the SFRP4+ PRG4+ Fibroblast Subpopulation in the Dermis of Healthy Skin and Its Relationship to SFRP4+ PRG4- Myofibroblasts in the Skin of Patients with Systemic Sclerosis
Location: Poster Hall
Abstract Poster Presenter: Banafsheh Nazari, MSc (she/her/hers) – Morehouse School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2368: Is Skin Disease a Local Manifestation of Systemic Tissue Turnover? Serological Collagen Biomarkers Provide Important Information on Skin Diseases Arising from Mutations in Collagen Genes
Location: Poster Hall
Abstract Poster Presenter: Helena Port I Linares, MSc – Nordic Bioscience A/S / University of Copenhagen
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT
2369: Investigating Macrophage Heterogeneity in the Esophagus of SSc Patients
Location: Poster Hall
Abstract Poster Presenter: Hadijat Makinde, PhD – Northwestern University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
2:00 PM – 3:00 PM PT
14T145: State of the Art: IgG4-Related Disease from Bench to Bedside
Location: Room 33A-C
Moderator: Mollie Carruthers, MD, FRCPC, ABIM – Vancouver General Hospital
Moderator: Arezou Khosroshahi, MD – Emory University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
CME: 1 hours
Tuesday, Nov 14th
2:00 PM – 2:15 PM PT
Defining the Clinical Phenotype of IgG4-Related Disease: Lessons from the ACR/EULAR Classification Criteria
Location: Room 33A-C
Speaker: John H Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
2:15 PM – 2:30 PM PT
B Cells, T Cells, and Immune-Mediated Fibrosis in IgG4-related Disease
Location: Room 33A-C
Speaker: Cory Perugino, DO – Massachusetts General Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
2:30 PM – 2:45 PM PT
Treatment and Monitoring of IgG4-Related Disease
Location: Room 33A-C
Speaker: Emanuel Della Torre – Ospedale San Raffaele
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tuesday, Nov 14th
2:45 PM – 3:00 PM PT
Q&A
Location: Room 33A-C
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
11:00 AM – 12:30 PM PT
15W125: Abstracts: Systemic Sclerosis & Related Disorders III: Clinical Trials (2593–2598)
Location: Room 32A-B
Abstract Moderator: Jessica Gordon, MD, MSc – Hospital for Special Surgery
Abstract Moderator: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
11:00 AM – 11:10 AM PT
2593: FT011 for the Treatment of Systemic Sclerosis. Results from a Phase II Study
Location: Room 32A-B
Presenting Author: Christopher Denton, MD, PhD – University College London, UK
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
11:15 AM – 11:25 AM PT
2594: Trajectories of Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Location: Room 32A-B
Presenting Author: Oliver Distler, MD – Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
11:30 AM – 11:40 AM PT
2595: A Randomized Controlled Trial to Compare the Efficacy and Safety of Tacrolimus with Mycophenolate Mofetil in Patients with Systemic Sclerosis - Interstitial Lung Disease ( INSIST TRIAL)
Location: Room 32A-B
Presenting Author: Shefali Sharma, Sr, MD, MBBS (she/her/hers) – Government
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
11:45 AM – 11:55 AM PT
2596: Head-To-Head Comparison of the Effectiveness of Tocilizumab, Rituximab, Mycophenolate Mofetil, and Cyclophosphamide in Patients with SSc-ILD from the EUSTAR Database
Location: Room 32A-B
Presenting Author: Qingran Yan, MD, PhD (she/her/hers) – Department of Rheumatology, University Hospital Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
12:00 PM – 12:10 PM PT
2597: Fecal Microbiota Transplantation in Patients with Systemic Sclerosis and Lower Gastrointestinal Tract Symptoms: Data from the ReSScue Phase 2 Randomized Clinical Trial
Location: Room 32A-B
Presenting Author: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Wednesday, Nov 15th
12:15 PM – 12:25 PM PT
2598: 6 Months-follow up Data of Systemic Sclerosis Patients Treated with CD 19 Targeting CAR-T Cells
Location: Room 32A-B
Presenting Author: Janina Auth, MD (she/her/hers) – University Hospital Erlangen, Medicine 3
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)